Hidemasa Kawabata

Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB

T. Okumura, Hiroki Sato, Y. Omori, 2019, Endoscopy International Open.

Damage control surgery for grade IV blunt hepatic injury with multiple organ damage in a child: a case report

H. Miyagi, S. Ishitoya, Seiya Ishii, 2021, Surgical Case Reports.

Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model.

T. Okumura, M. Fujiya, Tetsuhiro Okada, 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

A high-throughput sequence analysis of Japanese patients revealed 11 candidate genes associated with type 1 autoimmune pancreatitis susceptibility

Y. Kohgo, M. Fujiya, K. Moriichi, 2016, Biochemistry and biophysics reports.

Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance

T. Okumura, T. Yokochi, N. Sakamoto, 2020, Journal of Gastroenterology.

Multiplex digital PCR assay to detect multiple KRAS and GNAS mutations associated with pancreatic carcinogenesis from minimal specimen amounts.

Y. Omori, Tetsuhiro Okada, A. Katanuma, 2023, The Journal of molecular diagnostics : JMD.

Utility of “liquid biopsy” using pancreatic juice for early detection of pancreatic cancer

T. Okumura, K. Nagashima, Y. Omori, 2018, Endoscopy International Open.

Time-saving method for directly amplifying and capturing a minimal amount of pancreatic tumor-derived mutations from fine-needle aspirates using digital PCR

T. Okumura, Tetsuhiro Okada, R. Wada, 2020, Scientific Reports.

Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway

T. Okumura, Tsuyoshi Watanabe, M. Fujiya, 2022, Journal of gastroenterology.

The Effectiveness of the Combination of Arterial Infusion Chemotherapy and Radiotherapy for Biliary Tract Cancer: A Prospective Pilot Study

M. Fujiya, Tetsuhiro Okada, S. Fujibayashi, 2023, Cancers.